Who makes morinidazole?

morinidazole is developed by Hansoh.

What development phase is morinidazole in?

morinidazole is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

morinidazole

Hansoh · FDA-approved active Small molecule Quality 13/100

At a glance

Generic name	morinidazole
Sponsor	Hansoh
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease (PHASE4)
A Trial to Assess the Efficacy and Safety of Morinidazole in Patients With Appendicitis (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

morinidazole CI brief — competitive landscape report
morinidazole updates RSS · CI watch RSS
Hansoh portfolio CI